Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Ibrahim Aldoss(City of Hope), Betsy Blunk(Sarah Cannon), Rawan Faramand(Moffitt Cancer Center), Danielle Bradshaw(Augusta University Health), Joshua Sasine(Cedars-Sinai Medical Center), Catherine J. Lee(University of Utah), Kristen M. O’Dwyer(University of Rochester Medical Center), Simone E. Dekker(Oregon Health & Science University), Paul Shaughnessy(CHRISTUS Transplant Institute), Santiago Mercadal(Huntsman Cancer Institute), Navneet S. Majhail(Sarah Cannon), Divya Koura(University of California San Diego), Matthew P. Connor(Hospital of the University of Pennsylvania), Akash Mukherjee(University of Arkansas Medical Center), Marc S. Schwartz(University of California San Diego), Luke Mountjoy(Colorado Blood Cancer Institute), Gregory W. Roloff(University of Chicago), Noam E. Kopmar(University of Washington), Muthu Veeraputhiran(University of Arkansas Medical Center), Evan C. Chen(Dana-Farber Cancer Institute), Rasmus T. Hoeg(University of California, Davis), LaQuisa C. Hill(Baylor College of Medicine), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Ibrahim N. Muhsen, Vamsi Kota(Augusta University), Caitlin Guzowski(Northside Hospital), Talal Hilal(WinnMed), Chenyu Lin(Duke University), Aaron C. Logan(University of California, San Francisco), Minoo Battiwalla(Sarah Cannon), Sean Tracy(Broad Institute), Kaitlyn C. Dykes(University of California San Diego), John A. Mathews(Macquarie University), Abdullah Ladha(University of Southern California), Anjali S. Advani(Cleveland Clinic), Yannis K. Valtis(Brigham and Women's Hospital), Timothy E. O’Connor(University of Northern Iowa), Nikeshan Jeyakumar(Stanford Blood Center), Vishal Gupta(National Institute of Pharmaceutical Education and Research - Ahmedabad), Amy Zhang, Mohamed Ahmed(The University of Texas MD Anderson Cancer Center), Michal Jakub Kubiak(Augusta University Health), Shahbaz A. Malik(University of Nebraska at Omaha), Maryann Stefan(Cleveland Clinic), Héctor Zambrano(Sarah Cannon), Katherine C. Sutherland(Stanford University), Jozal Moore(University of Rochester Medicine), Katharine Miller(Stanford University), Melhem Solh(Johns Hopkins Hospital)
Cited by 12
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442